HEPATITIS MONTHLY, cilt.10, sa.4, ss.289-293, 2010 (SCI-Expanded)
Background and Aims: We aimed to evaluate the effectiveness of nucleoside analogues such as Lamivudine, Adefovir, Entacavir, and Tenofovir in patients with chronic hepatitis B who failed to respond to interferon therapy and relapsed.